Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Net Income - Minority (2016 - 2026)

Cumberland Pharmaceuticals' Net Income - Minority history spans 14 years, with the latest figure at $336100.0 for Q4 2025.

  • On a quarterly basis, Net Income - Minority rose 9.29% to $336100.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $336100.0, a 9.29% increase, with the full-year FY2025 number at $336100.0, up 9.29% from a year prior.
  • Net Income - Minority hit $336100.0 in Q4 2025 for Cumberland Pharmaceuticals, up from $307517.0 in the prior quarter.
  • Over the last five years, Net Income - Minority for CPIX hit a ceiling of $336100.0 in Q4 2025 and a floor of $139283.0 in Q1 2021.
  • Historically, Net Income - Minority has averaged $231813.0 across 3 years, with a median of $225934.5 in 2021.
  • Biggest five-year swings in Net Income - Minority: skyrocketed 195.44% in 2021 and later grew 9.29% in 2025.
  • Tracing CPIX's Net Income - Minority over 3 years: stood at $144352.0 in 2021, then surged by 113.03% to $307517.0 in 2024, then rose by 9.29% to $336100.0 in 2025.
  • Business Quant data shows Net Income - Minority for CPIX at $336100.0 in Q4 2025, $307517.0 in Q4 2024, and $144352.0 in Q2 2021.